Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,657 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos).
de la Torre-Hernández JM, Alfonso F, Hernández F, Elizaga J, Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, Perez de Prado A, Hernández JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman M, Diarte JA, Rodríguez-Collado J, Rumoroso JR, Lopez-Minguez JR, Mauri J; ESTROFA Study Group. de la Torre-Hernández JM, et al. Among authors: hernandez f, hernandez jm. J Am Coll Cardiol. 2008 Mar 11;51(10):986-90. doi: 10.1016/j.jacc.2007.10.057. J Am Coll Cardiol. 2008. PMID: 18325436 Free article.
Thrombosis of second-generation drug-eluting stents in real practice results from the multicenter Spanish registry ESTROFA-2 (Estudio Español Sobre Trombosis de Stents Farmacoactivos de Segunda Generacion-2).
de la Torre Hernández JM, Alfonso F, Gimeno F, Diarte JA, Lopez-Palop R, Pérez de Prado A, Rivero F, Sanchis J, Larman M, Diaz JF, Elizaga J, Moreiras JM, Gomez Jaume A, Hernández JM, Mauri J, Recalde AS, Bullones JA, Rumoroso JR, Del Blanco BG, Baz JA, Bosa F, Botas J, Hernández F; ESTROFA-2 Study Group. de la Torre Hernández JM, et al. Among authors: hernandez f, hernandez jm. JACC Cardiovasc Interv. 2010 Sep;3(9):911-9. doi: 10.1016/j.jcin.2010.06.010. JACC Cardiovasc Interv. 2010. PMID: 20850089 Free article.
Comparison of paclitaxel-eluting stents (Taxus) and everolimus-eluting stents (Xience) in left main coronary artery disease with 3 years follow-up (from the ESTROFA-LM registry).
De la Torre Hernandez JM, Alfonso F, Sanchez Recalde A, Jimenez Navarro MF, Perez de Prado A, Hernandez F, Abdul-Jawad Altisent O, Roura G, Garcia Camarero T, Elizaga J, Rivero F, Gimeno F, Calviño R, Moreu J, Bosa F, Rumoroso JR, Bullones JA, Gallardo A, Fernandez Diaz JA, Ruiz Arroyo JR, Aragon V, Masotti M; ESTROFA-LM Study Group. De la Torre Hernandez JM, et al. Among authors: hernandez f. Am J Cardiol. 2013 Mar 1;111(5):676-83. doi: 10.1016/j.amjcard.2012.11.019. Epub 2012 Dec 27. Am J Cardiol. 2013. PMID: 23273715 Clinical Trial.
Comparison of paclitaxel and everolimus-eluting stents in ST-segment elevation myocardial infarction and influence of thrombectomy on outcomes. ESTROFA-IM study.
de la Torre Hernández JM, Alfonso F, Martin Yuste V, Sánchez Recalde A, Jimenez Navarro MF, Pérez de Prado A, Hernández F, Abdul-Jawad Altisent O, Roura G, García Camarero T, Elizaga J, Calviño R, Moreu J, Bosa F, Jimenez Mazuecos J, Ruiz-Arroyo JR, Garcia Del Blanco B, Rumoso JR; ESTROFA-IM study group. de la Torre Hernández JM, et al. Among authors: hernandez f. Rev Esp Cardiol (Engl Ed). 2014 Dec;67(12):999-1006. doi: 10.1016/j.rec.2014.01.019. Epub 2014 Jun 7. Rev Esp Cardiol (Engl Ed). 2014. PMID: 25432710
Dual Antiplatelet Therapy for 6 Months vs 12 Months After New-generation Drug-eluting Stent Implantation: Matched Analysis of ESTROFA-DAPT and ESTROFA-2.
de la Torre Hernández JM, Oteo Domínguez JF, Hernández F, García Camarero T, Abdul-Jawad Altisent O, Rivero Crespo F, Cascón JD, Zavala G, Gimeno F, Arrebola Moreno AL, Andraka L, Gómez Menchero A, Bosa F, Carrillo X, Sánchez Recalde Á, Alfonso F, Pérez de Prado A, López Palop R, Sanchis J, Diarte de Miguel JA, Jiménez Navarro M, Muñoz L, Ramírez Moreno A, Tizón Marcos H; ESTROFA-DAPT and ESTROFA-2 study groups. de la Torre Hernández JM, et al. Among authors: hernandez f. Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):838-45. doi: 10.1016/j.rec.2015.01.008. Epub 2015 Jun 11. Rev Esp Cardiol (Engl Ed). 2015. PMID: 26072146
Immediate and Long-Term Results of Drug-Eluting Stents in Mammary Artery Grafts.
Lozano I, Serrador A, Lopez-Palop R, Lasa G, Moreu J, Pinar E, de Prado AP, Alfonso F, Jimenez Navarro M, Quero MF, Pineda J, Martin Moreiras J, Garcia San Roman K, Lopez Minguez JR, Suarez Cuervo A, Gutierrez A, Hernandez F, Baz JA, Benedicto A, Rumoroso JR, Gomez-Hospital JA, Serra V, de la Torre JM, Ruiz-Quevedo V, Botas J, Fernandez JA, Sanchez-Recalde A. Lozano I, et al. Among authors: hernandez f. Am J Cardiol. 2015 Dec 1;116(11):1695-9. doi: 10.1016/j.amjcard.2015.08.040. Epub 2015 Sep 10. Am J Cardiol. 2015. PMID: 26433270
Acute Coronary Syndromes, Gastrointestinal Protection, and Recommendations Regarding Concomitant Administration of Proton-Pump Inhibitors (Omeprazol/Esomeprazole) and Clopidogrel.
Lozano I, Sanchez-Insa E, de Leiras SR, Carrillo P, Ruiz-Quevedo V, Pinar E, Gopar-Gopar S, Bayon J, Mañas P, Lasa G, CruzGonzalez I, Hernandez F, Fernandez-Portales J, Fernandez-Fernandez J, Pérez-Serradilla A, de la Torre Hernandez JM, Gomez-Jaume A. Lozano I, et al. Among authors: hernandez f. Am J Cardiol. 2016 Feb 1;117(3):366-8. doi: 10.1016/j.amjcard.2015.11.007. Epub 2015 Nov 18. Am J Cardiol. 2016. PMID: 26708640
Percutaneous intervention in chronic total coronary occlusions caused by in-stent restenosis: procedural results and long-term clinical outcomes in the TORO (Spanish registry of chronic TOtal occlusion secondary to an occlusive in-stent RestenOsis) multicentre registry.
de la Torre Hernandez JM, Rumoroso JR, Subinas A, Gonzalo N, Ojeda S, Pan M, Martín Yuste V, Suárez A, Hernández F, Teruel L, Moreu J, Cubero JM, Cascón JD, Vinhas H, Lozano Í, Martin Moreiras J, Pérez de Prado A, Goicolea J, Escaned J. de la Torre Hernandez JM, et al. Among authors: hernandez f. EuroIntervention. 2017 Jun 2;13(2):e219-e226. doi: 10.4244/EIJ-D-16-00764. EuroIntervention. 2017. PMID: 27993757 Free article.
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.
Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators. Vaduganathan M, et al. J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055. J Am Coll Cardiol. 2017. PMID: 28081827 Free article. Clinical Trial.
1,657 results